Literature DB >> 30798264

Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis.

Manabu Mochizuki1,2, Justine R Smith3, Hiroshi Takase4, Toshikatsu Kaburaki5, Nisha R Acharya6, Narsing A Rao7.   

Abstract

AIMS: International criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an international meeting. This manuscript was aimed at reporting the revised IWOS criteria.
METHODS: A consensus workshop was carried out to discuss and revise the IWOS criteria. The workshop was held on 27 April 2017, in Nusa Dua, Bali, Indonesia. Prior to the workshop, a questionnaire proposing revised criteria and consisting of one item for differential diagnosis, seven items for ocular clinical signs, 10 items for systemic investigations and three categories of diagnostic criteria was circulated to 30 uveitis specialists. Questionnaire items with over 75% support were taken as consensus agreement; items with below 50% support were taken as consensus disagreement and items with 50%-75% support were discussed at the workshop. Of the latter items, those supported by two-thirds majority in the workshop were taken as consensus agreement.
RESULTS: The survey and subsequent workshop reached consensus agreements of the revised criteria for the diagnosis of OS as follows: (1) other causes of granulomatous uveitis must be ruled out; (2) seven intraocular clinical signs suggestive of OS; (3) eight results of systemic investigations in suspected OS and (4) three categories of diagnostic criteria depending on biopsy results and combination of intraocular signs and results of systemic investigations.
CONCLUSIONS: Revised IWOS criteria were proposed by a consensus workshop. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  inflammation

Mesh:

Year:  2019        PMID: 30798264     DOI: 10.1136/bjophthalmol-2018-313356

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  37 in total

1.  A 46-Year-Old Presenting With Inferior Mononuclear Visual Field Defect as the Sole Manifestation of Neurosarcoidosis.

Authors:  Carl Hoegerl; Addie Amper
Journal:  Cureus       Date:  2021-02-02

2.  Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis.

Authors:  Ryuto Nishisho; Sentaro Kusuhara; Noriyuki Sotani; Kyong Woo Kim; Atsuko Katsuyama-Yoshikawa; Wataru Matsumiya; Kengo Akashi; Akio Morinobu; Makoto Nakamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-01-07       Impact factor: 3.117

3.  Comments on the paper "Clinical characteristics and treatment of pars planitis: an adalimumab experience" by Ozdemir et al.

Authors:  Francois Pepin; Rachael L Niederer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-11       Impact factor: 3.117

4.  Could different aqueous humor and plasma cytokine profiles help differentiate between ocular sarcoidosis and ocular tuberculosis?

Authors:  L De Simone; M Bonacini; S Croci; L Cimino; R Aldigeri; F Alessandrello; V Mastrofilippo; F Gozzi; E Bolletta; C Adani; A Zerbini; G M Cavallini; L Fontana; C Salvarani
Journal:  Inflamm Res       Date:  2022-06-28       Impact factor: 6.986

5.  Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population.

Authors:  Gerard Reid; Michael Williams; Marie Compton; Giuliana Silvestri; Clara McAvoy
Journal:  Eye (Lond)       Date:  2021-09-23       Impact factor: 4.456

6.  An Unusual Presentation of Neurosarcoidosis.

Authors:  Erdal Sarac; Sergul A Erzurum; Ali Arif
Journal:  Am J Case Rep       Date:  2022-09-27

Review 7.  [Association of the different forms of uveitis with inflammatory rheumatic diseases and their treatment].

Authors:  Nicole Stübiger; Sanaz Farrokhi; Yannik Gkanatsas; Christoph Deuter; Ina Kötter
Journal:  Z Rheumatol       Date:  2022-08-30       Impact factor: 1.530

8.  Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.

Authors:  Katsuya Nagahori; Hiroshi Keino; Makiko Nakayama; Takayo Watanabe; Yoshimasa Ando; Isami Hayashi; Shinya Abe; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-26       Impact factor: 3.535

9.  Development of a Nationally Agreed Core Clinical Dataset for Childhood Onset Uveitis.

Authors:  Ameenat Lola Solebo; Salomey Kellett; Jugnoo Rahi; Reshma Pattani; Clive Edelsten; Andrew D Dick; Alastair Denniston
Journal:  Front Pediatr       Date:  2022-06-21       Impact factor: 3.569

10.  Incidence and changing patterns of uveitis in Central Tokyo.

Authors:  Takafumi Suzuki; Toshikatsu Kaburaki; Rie Tanaka; Shintaro Shirahama; Keiko Komae; Hisae Nakahara; Mitsuko Takamoto; Hidetoshi Kawashima; Makoto Aihara
Journal:  Int Ophthalmol       Date:  2021-05-28       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.